Bioethics, Medical
Ethics and Health Law
Programme and
Book of Abstracts
Royal Continental Congress Centre
Naples, Italy
November 19-21, 2013
Secretariat: ISAS International Seminars, POB 574, Jerusalem 91004, Israel, Tel: +972-2-6520574, seminars@isas.co.il
Table of Contents
Programme at a Glance
2-3
Social Programme
General Information
10
11
Tuesday, November 19
13
Wednesday, November 20
20
Thursday, November 21
31
Poster Presentations
35
Abstracts
Oral Presentations (alphabetical order by author)
Poster Presentations (by day and by presenter)
37
167
Tuesday, November 19
169
Wednesday, November 20
177
Social Programme
Tuesday, November 19 - 19:00 in Hotel Restaurant
Welcome Gala Get-together Dinner with Musical Accompaniment
Wednesday November 20
19:30 Musical Performance in Hall A - Amelia and Francesca
Rondinella preceded with wine and socializing
21:00 Farewell Dinner in Hotel Restaurant
Optional Tours: See conference registration desk
185
inside back cover
Education Department
Argentina: Moty Benyakar
Australia: Irina Pollard, Russell DSouza, Giuliana Fuscaldo
Azerbaijan: Vugar Mammadov
Bulgaria: Sashka Popova
Canada: Joel Lamoure
Israel: Guy Enosh
Italy: Fulvia DeMatteis, Anna Maria Traversa,
Miroslava Vasinova
Nigeria: Yohanna Dangata
Serbia: Zoran Todorovic
USA: Miriam Cotler
Research Department
Albania: Altin Stafa
Argentina: Juan Jorge Michel Farina
Armenia: Susanna Davtyan
Australia: Michael Lupton, Russell DSouza, Giuliana
Fuscaldo, Mirko Garasic
Austria: Gabriele Werner-Felmayer
Belgium: Laurent Ravez
Brazil: Jose Thome
Bulgaria: Sashka Popova
Canada: Joel Lamoure
Czech Republic: Renata Veselska
Georgia: Irma Manjavidze, Eka Sanikidze
Israel: Guy Enosh, Yoram Blachar, Haim Knobler
Italy: Miroslava Vasinova, Paolo Benanti, Nunzia
Cannovo, Rosa Maria, Gaudio, Pasquale Giustiniani,
Alessandra Pentone, Anna Maria Traversa
Japan: Mitsuyasu Kurosu
Macedonia: Mentor Hamiti
Mexico: Ma de Luz Casas-Martinez
Nigeria: Yohanna Dangata
Serbia: Jovan Babic, Dragoslav Marinkovic, Vojin Rakic
South India: Princy Louis Palaty
Switzerland: Lazare Benaroyo
Taiwan: Daniel Fu-Chang Tsai
UK: Rhys Carwyn-Hooper
USA: Terry Bard, Miriam Cotler, Kenneth Goodman
10
General Information
Conference Venue:
Halls A-H
Royal Continental Congress Center
Via Partenope 38-44
Naples, Italy
Tel. 081.7644621
Halls I-K
LOrientale University
Palazzo Du Mesnil
Via Partenope 10/A - 80121
Naples
Tel. 081.6909121
(5 minutes walk from venue - see map on inside back cover)
Hospitality desk:
November 19 and November 20: 09:00-18:30
November 21:
09:00-14:00
Tours:
For further information and questions about
tours, please contact the hospitality desk.
Dine Around:
A list of nearby recommended restaurants will be
provided at the conference.
Bioethics, Medical
Ethics and Health Law
Scientific Programme
Oral Presentations
Poster Presentations
13
Your own personal genome: ethical issues in directto-consumer (DTC) genomics services
Amy Michelle DeBaets, USA
09:00-10:30
CONSULTA WORKSHOP (1)
Hall B
ETHICS AND MEDICINE: ISSUES AND PROBLEMS IN
SOME AWARD AREAS I
Co-Chairs: Paolo Procaccianti, Filiberto Cimino
Current legislation in the field of preimplantation
genetic diagnosis in European Union members
Francesco Paolo Busard, Italy
Which consent in biobank-based research
Gianluca Montanari Vergallo, Italy
The donation of a persons body after death: a question
of ethics and science
Alessandro Bonsignore, Italy
Clinical experimentation on vulnerable subjects: issues
on the evaluation of a study on patients of the Italian
secure hospitals (OPG)
Valeria Marino, Italy
Immigrants! How Italian emergency health workers
perceive the other patients
Paola Antonella Fiore, Italy
Treatment prospects in sex offenders with paraphilic
disorders: pharmacological androgen deprivation
between the need for social defense and the right to
health
Roberta Carrossino, Italy
Hall E
Hall F
Hall G
14
Hall K
ETHICS EDUCATION
Hall I
Co-Chairs: Assya Pascalev, Washirasorn Saengsuwan
Developing ethical understanding and designing a
rubric to measure progress
Marie Catherine Letendre, Italy
The interdisciplinary ethics course at Howard University
Health Sciences Center: a model of ethics education
for in the 21st Century
Assya Pascalev, USA
Training the moral muscle: a competencies based
approach to the teaching and evaluation of
professional ethics
Johannes Renders, The Netherlands
Ethical behavior in temporal perspective: ethical mirage
phenomenon in applied ethics
Daniela Sotirova, Bulgaria
Thai teachers opinions and reflective thinking on
ethics in science from participating in an academic
service project for science teacher development
Washirasorn Saengsuwan, Thailand
OPENING SESSION
Hall A
15
9
12:30-13:30
Optional lunch break and poster session
GENETICS (2)
Co-Chairs: Froldi Rino, Catanesi Roberto
13:30-15:00
Hall D
Hall C
Hall G
16
Tuesday,
November
19, 2013
Scientific
Programme
Migrating modernitys
Ian Chambers, Italy
17
9
Hall F
Hall G
Hall H
Hall E
18
9
Hall B
ETHICS KNOWLEDGE OF
Hall K
HEALTH CARE WORKERS
Co-Chairs: Dilara Mamedaliyeva, Maurizio Carnassale
Current level of knowledge, perception and practice
of medical law and ethics among Nigerian medical
practitioners: deficiencies and remedies - the Nigerian
model
Awawu Grace Nmadu, Nigeria
About nurses knowledge of medical deontology
Dilara Mamedaliyeva, Azerbaijan
The international code of ethics for occupational health
professionals: a guide for the physicians who work for
Italian Workers Compensation Authority
Maurizio Carnassale, Italy
16:30-17:00
Coffee break and poster session
17:00-18:30
Hall A
EUROPEAN SOCIETY FOR
CARDIOVASCULAR SURGERY WORKSHOP
BIOETHICAL ISUES IN CARDIOVASCULAR SURGERY:
NEW TECHNOLOGIES, NEW FRONTIERS, NEW RULES?
Co-Chairs: Domenico Palombo, Oto Oztekin
The need of ethical training for cardiovascular surgeons
Domenico Palombo, Italy
ECMO: limits and indications, a bioethical discussion
Oto Oztekin, Turkey
EVAR for abdominal aortic aneurysm in elderly patients:
bioethical issues
Lazar Davidovic, Serbia
Peripheral arteriopaty and diabetic patients in
endovascular era: is it bioethically worthwhile?
Giancarlo Bracale, Italy
Hall C
Discussion
Election of SIOF President and Assembly
ABORTION
Co-Chairs: Laura Andrissi, Sara Dejevsarov
Hall D
Hall G
BIOETHICS EDUCATION (4)
Co-Chairs: Sashka Popova, Siti Pariani
Hall F
19
9
Hall H
Hall J
Hall K
20
09:00-10:30
Hall A
AOGOI WORKSHOP (1)
ETHICAL DIMENSIONS OF OBSTETRICS & GYNECOLOGY I
Co-Chairs: Vito Trojano, Antonio G. Spagnolo
Hall D
Hall G
21
9
10:30-11:00
Coffee break and poster session
11:00-12:30
Principles of the education in bioethics and ecobioethics in medical schools and to the healths
professionals in hospitals in So Paulo
Jose T. Thom, Brazil
Bioethics education on vulnerable subjects and groups
Zoran Todorovi , Serbia
Emotional intelligence as methodology and didactic
tool in teaching bio-ethics at nursing schools: practical
steps
Daniella Keidar, Israel
A disability bioethics curriculum that encourages
reflection and open discussion among students and
community members
Julie Rogers, USA
Hall K
Hall J
Hall A
22
Hall D
Hall H
23
9
Hall K
The spiritual assistance
Adolfo Russo, Italy
13:30-15:00
NAPLES FEDERICO II UNIVERSITY ETHICS
COMMITTEE WORKSHOP (1)
ORGAN TRANSPLANTATION
Co-Chairs: Enrico Di Salvo, Roberto Catanesi
Hall A
Futile trials: ethical issues
Massimo Niola, Italy
Hall D
Hall B
24
Hall I
Hall G
Hall J
Hall H
Hall A
25
9
Hall B
Hall D
Hall E
26
Hall G
MULTICULTURALISM (1)
Hall K
Co-Chairs: Aline Albuquerque, Maria Teresa Tassinari
Hall H
Hall B
27
9
Hall D
Hall F
28
Hall G
Hall H
Hall J
29
9
Hall E
Hall G
30
Hall H
Hall K
10:30-11:00
Coffee break and poster session
11:00-12:30
FNOMCeO /NATIONAL FEDERATION OF
Hall A
ORDERS OF PHYSICIENS & DENTISTS/WORKSHOP (1)
MEDICAL DEONTOLOGY
Co-Chairs: Antonio D'Avanzo, Angelo Fiori
Ethics, bioethics and medical deontology
Aldo Pagni, Italy
vegetative state
Marina Manera, Italy
Responsibility construction
Ines Giorgi, Italy
31
9
Hall D
Hall I
32
Hall C
12:30-14:00
FNOMCeO /NATIONAL FEDERATION OF
Hall A
ORDERS OF PHYSICIANS & DENTISTS/WORKSHOP (2)
BALANCE BETWEEN DEONTOLOGY AND LEGISLATION
Co-Chairs: Bruno Zuccarelli, Gian Aristide Norelli
Informed consent and advance directives for treatment
Roberto Longhin, Italy
Hall D
FORENSIC MEDICINE
Hall G
Co-Chairs: Olufumilayo Yetunde Elegba, Andrea Baloghov
Development of molecular pathology infrastructure
in Nigeria: The emerging opportunities, legal and
ethical implications
Olufumilayo Yetunde Elegba, Nigeria
Ethical and legal problems in forensic medicine in Slovakia
Andrea Baloghov, Slovakia
WAR, SECURITY AND ETHICS
Co-Chairs: Mohd Zin Bidin, Barry Roth
Hall H
Hall I
Hall E
33
Hall F
Hall J
34
Poster Presentations
Tuesday, November 19, 2013
T01
Acquisition of consent to medical treatment under
mandatory health: simple binding legal or the main
instrument for the promotion of therapeutic
relationship
Cristiano Barbieri, Italy
T02
Stability over time in the preferences of older persons
for life-sustaining treatment
Ins Maria Barrio Cantalejo, Spain
T03
Assisted reproduction in Italy: bioethical, juridical and
medico-legal dilemmas
Rosagemma Ciliberti, Italy
T04
Prison treatment and ethical dimension
Paolo Danesino, Italy
T05
Moral and legal responsibilities - dilemmas faced
in pharmacy - experiences from the Republic of
Macedonia
Merita Dauti, Republic of Macedonia
T06
Ethical standards and normative regulations in
the field of medical care in emergency situations
Alena Donika, Russia
T07
Linguistic and cultural validation of an instrument for
the analysis of ethical values of nursing students with
special reference to honesty and altruism
Stefano Finotto, Italy
T08
The act ethics in health care: the path of ethics
Raffaela Genzale, Italy
T09
The Interuniversity Research Centre on Bioethics of
Naples - activities on the bioethics of the beginning
life
Pasquale Giustiniani, Italy
T10
Current status of institutional review boards and
approvals of clinical research in oriental medical
hospitals in Korea: a survey
Jung Hee-Jung, South Korea
T11
Attitude, practice of clinical physicians in Vietnam
on medical errors and conflict of interest
Tran Thi Thanh Huong, Vietnam
T12
Preventive mastectomy: overtreatment or personal
harm?
Francesco Introna, Italy
T13
The cloning and its ethical-legal implications
Fatbardha Ismaili, Republic of Macedonia
35
T14
Dealing with violence in a combined organizational
structure - an instructive response from a therapeutic,
ethical and safety perspective
Ronit Kigli, Israel
T15
Health care guarantee in secondary health care telemedicine to the rescue
Hanna Kuusisto, Finland
T16
Missing person DNA data-base to counteract the illegal
traffic of organs
Massimo Lancia, Italy
T17
The foundations of the Italian medical ethics following
the finding of the Professional Codes of the Medical
Chamber of Istria (1897) and of the Medical Chamber
of Trento (1900)
Sara Patuzzo, Italy
T18
Emotional communication in helping relationships for
the treatment of disorders related to new forms of
addiction
Rocco Quagliariello, Italy
T19
A pilot study of pharmacy students perceptions
regarding ethical values, conscientious and religious
objections
Vojin Rakic, Serbia
T20
National growths characteristics of bioethics in Russia
Natalia Sedova, Russia
T21
Ethics, hemodialysis and patients with differing ages
Ronen Segev, Israel
T22
Professional dignity in nursing implicates patient safety
for Italian nurses
Alessandro Stievano, Italy
T23
The experience of ethics committees in the
Andalusian System of Public Health, Spain
Maribel Tamayo Velzquez, Spain
T24
Bioethics contribution to integral formation on higher
education
Valeria Trigueiro Santos Adinolfi, Brazil
36
Poster Presentations
Wednesday, November 20, 2013
W01
Ethical problems of integration of children with
disabilities in Bulgaria
Silviya Aleksandrova-Yankulovska, Bulgaria
W15
Post mortem fecundation rules in EU Members:
the usage of sperm after donors death
Paola Mancarella, Italy
W02
The Health Technology Assessment (HTA): the
distinction between innovation and new business
Rosalba Caldarazzo, Italy
W16
Archives of surgical pathology as a tool for
comprehension of biological behaviour of malignancies
Gabriele Margiotta, Italy
W03
Regional differences within the programmes of
screening for breast cancer: ethical problems of health
policy and management
Michelle Capasso, Italy
W17
Sensitization and incorporation of ethical practices in
pathology postgraduate curriculum in India
Mary Mathew, India
W04
Compassionate use: Italian case law
Irene Catarinozzi, Italy
W18
Impact of eastern socio cultural determinants on end
of life decision making
Princy Louis Palaty, India
W05
Accidental thawing of embryos and oocytes:
legal aspects and medico-legal profiles
Michela Cicconi, Italy
W19
Cultural and ethical issues on female genital mutilation:
the Italian situation
Laura Panata, Italy
W06
Ethics committees and GCP and GLP Rules
Susanna Davtyan, Republic of Armenia
W20
Bioethical aspects of pharmacotherapy of rare diseases
in Serbia: from the point of view of medical students
Milica Prostran, Serbia
W07
Socio-economic factors related to the withdrawal of
chloroquine (CQ) in the range of production plant
Malian pharmaceuticals
Samba Diop, Mali
W08
The future role of the invasive autopsy in the
investigation of deaths and possible alternatives
Italian Group of Young Medico-legal doctors
W09
The determination of death with regard to organ
transplantation: 20 min vs 2 min
Arianna Giovannetti, Italy
W10
Reasons for asylum seeking and medical certification
Luciano Gualdieri, Italy
W11
The European legal framework for Compassionate
Use Programmes: similarities and differences between
five member states to guarantee a better quality of
life in patients affected of seriously and/or chronic
debilitating or life-threatening diseases
Sara Hemied, Italy
W12
The use of unapproved drugs for compassionate use:
Italian law and re-emerging regulatory requirements
Laura Iovenitti, Italy
W13
Styles of bioethics education in Poland
Pawe ukw, Poland
W14
Nurses coping with ethical dilemmas during work
Helen Malka-Zeevi, Israel
W21
The ethics of treating adolescents with anorexia
nervosa: the case for justified paternalism
Tomas J. Silber, USA
W22
The strategic plan on bioethics of the Regional Ministry
of Health and Welfare of Andalusia (Spain): an
innovative experience in public policy
Pablo Simn-Lorda, Spain
W23
Should or must there be a finding of materiality
regarding, and disclosure of, physician financial conflicts
of interest that both patients want to know about
and that, when disclosed, affect their decisions whether
to accept care recommendations?
Roy G. Spece, USA
W24
Attitudes, perception and knowledge of bioethics
among physicians and post graduate trainees of
hospitals of Islamabad and adjacent regions
Rizwan Taj, Pakistan
Bioethics, Medical
Ethics and Health Law
Abstracts
Oral Presentations
(alphabetical order by author)
CONSCIENTIOUS OBJECTION
Franco Alberton, FNOMCeO Deontological Committee, Italy
deontologia@fnomceo.it
The term conscientious objection indicates a generic refusal to perform
actions which, even if imposed by law, are judged to be irreconcilable
with ethical, religious or ideological principals. Refusing treatment
assumes enormous relevance in the medical field, given the primary
interests of the individual and also the potential consequences for the
conscientious objectors of possible infringement of the law (omission).
There is, therefore, a difference between the objection contemplated and
allowed by the law as an exception to the obligation imposed and the
objection which, if implemented, constitutes an effective breach of the
law.
In Italy, conscientious objection as a right contemplated by law is
envisaged, in the health care context, in only three cases: in the
regulations on voluntary interruption of pregnancy, in medically assisted
procreation and in those regarding experimentation on animals.
Above all, in the first two cases the possible conflict with principles
deemed to be non-renounceable for a large number of citizens and,
therefore, also for many health operators, appears evident.
We can talk about illegal objection when the refusal involves actions
required by law without exceptions. In such cases, the person who raises
the conscientious objection and refuses the treatment may incur legal
consequences, while on a deontological level the problem may turn out to
be very complex. For the health operator, in fact, the possibility of
abstaining from activities which are in stark contrast with his/her
principles, is recognized. This right must, however, always find a just
equilibrium with the interests of the person who is requesting help.
39
40
L. Andrissi , G. Mottini
1
Tor Vergata University, Italy
2
Campus Bio-Medico University, Italy
l.andrissi@unicampus.it, g.mottini@unicampus.it
Several studies have showed a high rate of Induced Early Abortion (IEA)
among irregular immigrants and refugees (up to 50% of pregnancies)
especially for those coming from Sub-Saharian Africa.
100 women (aged 27 in mean, 43 IEA), temporary living in the two largest
Reception Centres for Asylum Seekers (CARA) in Europe (Crotone and
Mineo, Italy), were asked to fill a questionnaire for epidemiologic aspects,
and semi-structured interviews were performed to identify the
anthropologic and ethic triggers that push to IEA and find solutions. The
main languages were English and French.
Statistical analysis shows that to come from urban settings, to be single,
Nigerian, with a low educational level and a poor knowledge on
reproductive cycle and family planning methods (natural, chemical,
chirurgic), was related to IEA (p<0,05). The most influential factors driving
to IEA were economic and cultural (fear of parents, ashamed to be
misjudged). Cultural, ritual and religious beliefs (foetus identity, when he
became a living human being inside the womb) can be both, push and pull
factors. The lack of their enlarged family, migration experience, fear of
the future have an important influence for the choice. Interviews report
interesting aspects of narrative based medicine and show how loneliness
and fear are the root causes that drive to IEA. To strengthen women
personality, create educational and moral certainties and supporting
networks, aimed at irregular immigrants, inside and outside the CARA, to
find mothers, grandmothers and aunts substitutes, it may be the right key
to help them.
41
42
1,2
43
44
45
46
DECLARATION OF HELSINKI
Jeff Blackmer, Primary Ethics Advisor, World Medical Association;
Office of Ethics, Professionalism and International Affairs,
Canadian Medical Association, Canada
Jeff.Blackmer@cma.ca
Background: The Declaration of Helsinki (DoH) is generally considered to
be the pre-eminent guiding document in research ethics for physicians
participating in research studies, and for many Research Ethics
Committees around the world. First published in 1964, it has been
updated several times, most recently in 2008. By the time the UNESCO
meeting takes place, the WMA hopes to have completed another revision
47
As concerns the evaluation on criteria and the trials discipline, there are
Countries where clinical trials are submitted to only one law whereas in
others, like Italy, each aspect of scientific research is regulated by specific
norms.
In many European Countries like Turkey, a centralized procedure is
followed at national levels according to which it is the Ministry of Health
that express its judgment on the protocol under examination.
In other Countries research projects are evaluated at local (peripheral)
level.
In particular, at local level two typologies exist:
Regional or at district level (Belgium, Czech Republic, Finland, Latvia,
Lithuania, Netherlands, Norway, Slovenia, Sweden and Switzerland, and
the really local level of universities/hospitals (Italy, Bulgary, Estonia,
Germany, Ireland, Poland, Serbia, the United Kingdom, and Spain).
Almost all EU and ERA (European Research Area) countries have a
National Ethical Committee with leading functions for the other European
Countries, sometimes without any active role in the evaluation of the
trials, some other times acting as appeal evaluators of study projects
rejected at local level (Bulgaria, Cyprus, Denmark, Finland, France, Ireland,
Latvia, Lithuania, the Netherlands, Poland, Portugal, Switzerland, Sweden
and the United Kingdom).
In European Countries Ethical Committees, the layperson i.e. a member
who does not belong to the world of science and biology is present to
different extents, such as in Denmark where more than half of
Committees members are laypersons.
Another peculiar aspect is the number of local Committees.
Directive 2001/20EC following its principle of assigning trials to high
quality centers has eventually reduced the number of Committees in
Europe.
In Italy, Act 189/2012 dramatically reduced their number subject to the
population size (1/1.000.000) which involved a series of predictable
negative effects that will be analyzed in another paper.
48
The Italian legislation for WDT has been introduced by Unified Conference
no. 99/2007 and Law no. 81/2008 as improvement in safety, productivity
in the worksite and public health. The legislation calls for mandatory
procedures for screening tests (I Level) on biological samples for at-risk
workers, performed by occupational health specialists, and for
confirmatory tests by GC/MS or LC/MS/MS (II Level), performed by
forensic laboratories.
Therefore, the application of WDT implies some basic ethical principles,
that occupational health physicians and toxicologists need to employ, in
order to avoid the violation of the workers rights and to prevent disputes
about professional responsibility. These include, but are not limited to:
Right to Privacy and data protection: this is very important, since
WDT involves collecting sensitive data, both on use of drugs and about
medications taken which might influence the test result;
Informed consent: the employee has to know, ideally prior to taking
the job, that abstinence is an expectation, and that WDT is planned;
Quality assurance in Sample collection and screening/confirmation
testing: several critical factors can affect results, and lead to
administrative law disputes about use/non-use of illegal drugs. These
factors are numerous and consist primarily in specimen collection
procedures, chain of custody, contamination or adulteration of
samples, number of tested drugs and detection ranges, cut-off and
reliability of screening tests with regard to the differences in target
antigens. Therefore, it is necessary that WDT is conducted with
respect of analytical, legal and ethic issue in order to prevent damages
to workers through false positive results;
Provision of addiction counseling: this may include treatment and/or
rehabilitation in positive drug test cases, distinguishing between use
or abuse, with or without dependence;
Support in transitioning to more suitable employment if appropriate.
In this paper, some real cases are discussed, in order to highlight the
many ethical dilemmas posed by the management of alcohol and drug
problems in the workplace. These dilemmas involve a careful balancing
between the respect to involved individuals, and the obligation to
correctly manage the financial resources and to safeguard the safety of
other workers, especially when WDT involves the collecting of sensitive
data (such as the use of illegal drugs, or the assumption of medications).
In conclusion, WDT can have an important role in safety on workplace,
especially in the occupations where the employer and public is entitled to
expect the highest standards of safety and probity. Aside from this, there
is no justification for drug testing as a way of policing the private
behaviour of the workforce, nor is it an appropriate tool for dealing with
most performance issues. Even where drug testing does have a role it
should be approached with caution, and implemented in an ethical, fair,
transparent and inclusive way.
49
Ethical Use of Social Media, this white paper explores the existing
literature, focusing among others on the legal and ethical aspects of social
media use in medicine.
Results: Social media use by physicians raises various legal and ethical
implications. Posting of inappropriate, abusive, personal, malicious or offtopic material may lead to legal sanctions and threaten the credibility of
the medical profession. Disclosure of information causing disturbance or
substantial interference with the provision of health care and the
permanence of digital content transmitted online may also have legal
implications. Health-care gaps in social media access among patients of
lower socioeconomic status, pose further ethical considerations. Specific
forms of pathology, for example status anxiety and other maladaptive
behaviours have also been described in this new field. Secondary data
usage from social media for research or public health purposes raises a
number of issues pertaining to patient privacy and confidentiality.
Conclusion: It is apparent that many of the legal and ethical
considerations in the use of social media are already reflected in the
standards and codes set out by physicians, institutions and regulatory
bodies alike. It is therefore important for policymakers and stakeholders
involved to work together to address and develop standards for
optimising social media usage and mitigating potential risk. There is a
tremendous potential in harnessing social media for health care, but
equally large potential pitfalls must be considered.
50
51
submitted. Other times (6% of cases) the Promoters were formally invited
to adopt adequate insurance coverage.
Multiple insurance inadequacies were found in several research
protocols. Seven out of the 191 protocols, which modifications had been
requested for, were rejected for failure to comply with the requests for
changes made in relation to inadequate insurance coverage.
The results of our study reinforce our belief that damage compensation
guaranteed to people participating in a clinical trial, by means of a
suitable insurance policy, is an essential protection tool for an appropriate
balance between ethical values, clinical risks and economic interests.
52
53
informed con sent remains one of the most contested issues of biobank
policy, other ethical challenges also still require careful attention: these
include the protection of vulnerable subjects, the safeguarding of privacy,
the communication to donors of research results, conflicts over patenting,
access, and the need for open science, and the rights of donors to retain a
property claim or control over their tissues. Furthermore the ethics
consultant may be involved in a campaign of ethical education to ensure
that all researchers involved in biobanks are aware of their ethical
responsibilities, and donors are better equipped with an ethical
understanding of donation significance.
54
same, which considers and describes both the context in which intuition
arise, as well as its content or intentioned object. We exemplify this
new approach supporting the need to go beyond two extremes. On the
one hand, the anarchical conception of intuition, that is to say, the idea
that it is not possible to establish the conditions that favour its
emergence, on the other hand, the economization of intuition which
refers to its translation into a merely quantitative dimension.
55
56
57
58
The paper builds on the analysis of the profiles of the legal significance of
advance directives for medical treatment in Italy, and aims to highlight
the convergences and divergences between the Italian experience and
that of some other countries, not only in Europe (Spain, UK, Belgium,
Holland, Switzerland, Israel), which governed in a more or less organic and
complete the phenomenon of advance directives. The privileged
perspective of the comparison between different experiences allows you
to identify issues and difficulties that have been faced in all systems
considered, and, for this way, it allows to carry out a study to select and /
or develop possible proposals for solutions for these issues and
difficulties.
The broad list of subjects about which it is expected the discussion is as
follows:
1. Advance directives for medical treatment: problems and prospects in
the Italian experience. 2. Principles and solutions in Europe. - 2. The
experience of some European countries: the document de voluntades
anticipadas in Spain. -3. (continued) The living will in the UK. 4.
(continued) Statements assets and choices of euthanasia in Belgium,
Holland and Switzerland. - 5. The original approach adopted in the State
of Israel. - 6. Issues arising from the comparison between the experiences
examined and possible solutions.
59
60
MIGRATING MODERNITYS
Iain Chambers, University of Naples, Orientale, Italy
Speaker intends to talk of the refashioning of modern society, cultures
and identity in the light of the planetary migrations that have historically
constituted the hubris of the modern world. The principal scope of these
considerations is to render explicit the idea of migration as central to the
historical and cultural processes that continually renovate our being
positioned in planetary perspectives and possibilities. This, in turn,
transforms the question of migration from a marginalised socio-economic
problem into a profound critical challenge, leading to the adoption of
what we might consider to be the multiplicities of a migrating modernity
that is not only ours to define and manage.
61
62
63
64
1,2
1,2
65
66
67
68
69
70
the recipient country. Such programmes are usually only for short
periods. The present paper makes a critical analysis of vertical health
programmes with respect to their challenges, advantages, disadvantages
and ethical implications on Integrated Health Care Delivery Systems in
Africa. We undertook full searches (May 2003 - April, 2013) of original
research, reports and reviews using Medline, PubMed, Embase and World
Health Organisation (WHO) Databases. Search words were advantages,
Africa, disadvantages ethical implications, integrated health care
vertical programmes, vertical programmes and Africa. Findings show
that donor organizations usually offer their interventions with specific
regulations on the receiving countries. The stringent conditions and
procedures set by donors sometimes distort existing integrated
healthcare planning and budgeting of the recipient country. These
findings show that, in spite of huge resources invested in vertical health
programmes in Africa, some of them are still very far from achieving their
set goals and objectives. This results from their strict unilateral approach
in exclusion of horizontal programmes of recipient countries. We suggest
a complementary approach that would allow symbiosis of both vertical
programmes and integrated health care systems thus facilitating each
other to maximize their potential for efficiency and cost effectiveness of
their respective objectives.
Acknowledgements: Kaduna State University, Kaduna, Nigeria and Centre
for Biomedical Ethics and Law, KUL Leuven, Belgium for funding
71
for a solution. The ethical problem is that a kid can die because some
unauthorized person performed surgery without the essential sanitary
equipment. Given this emergency status, underlined by those who face
the immigrants problems daily, it seems indeed necessary to make a
further official step to avoid new tragedies, because Africans will in any
case keep performing circumcision. Either they go back to their country of
origin, or they fly to London, where the surgery can be carried out in
public hospitals. However, both solutions are extremely expensive, and
most immigrants cannot afford them. In Italy the circumcision surgery is
free in all cases of therapeutical prescription (for instance in cases of
phimosis). An obliging practitioner might prescribe circumcision even
though a real therapeutical need is not present. My intervention will
analyze the reasons for the health structures, describing the history,
evolution, and the conclusion, finally asking some important ethical
questions.
72
information before deciding about the fate of the biological material that
still belongs to them.
This form will be illustrated in the paper as well as the rules for filling it in.
73
74
75
person) and dignity of the person although pursuing their inherent goal of
acquiring new knowledge.
The Nuremberg Code was a turning point in the protection of the rights of
patients involved in experiments but only in later international ethics
documents the primacy and superiority of the individual over collective
interests in research protocols has been clearly stated.
The need for scientific trials to provide results that are useful for the
whole society is not ignored because otherwise trials on healthy
volunteers, which are of no direct usefulness to them, would not be
permitted.
Yet it has been clarified that the primary goal in scientific trials is to
acquire insights and find therapies useful for single individuals.
However, in our opinion the protection of the well-being and safety of
every single individual involved in a trial cannot be considered nowadays
in absolute terms with respect to the possibility of obtaining useful
knowledge for the whole society. After decades of trials on humans in
compliance with strict rules the authors deem there is new room, with all
due caution and juridical limitations, for solidarity-based derogations
from the individual psychophysical integrity principle in favour of the
society.
Hence, precise criteria are needed to allow for these derogations in
favour of the progress of mankind and in total safety. In this sense,
voluntarily giving up ones own psycho-physical integrity as a contribution
to research is not to be interpreted as a waiver of the constraints
protecting the individual rights of the patient involved in the experiment
but as the acceptance of risks by the patient after thorough assessment of
all time-related, dimensional, anatomical and functional aspects and
provided that all ethical and juridical norms are complied with.
1,2
1,2
76
77
78
79
their clinical practice. The study used the grounded theory method of
Strauss and Corbin with in-depth, semi-structured interviews to
understand the lived experiences of twenty eight (28) participant
physicians whose age ranged from 27-70 years.
After open coding of transcripts of interviews, axial coding and selective
coding of emerged concepts, six distinct yet related categories were
identified namely: a.) the nature of ethical dilemmas, b.) causal conditions
triggering the dilemmas, c.) contextual conditions of the ethical
challenges, d.) intervening conditions affecting the negotiation of the
dilemmas,
e.) action/ strategies in resolving the dilemmas and f.) outcome/
consequence of the decision on these ethical challenges. Several
attributes under each of the six major categories were identified by the
study.
From the results, it can be concluded that the overarching motivation of
physicians in the negotiation of ethical dilemmas is Doing Right for
Patients, the core category that emerged after analysis of data. It is the
category that ties up all the other categories and can explain the six
distinct but related subsidiary categories and their attributes. Several
factors were identified as having an influence in the decision making
process of physicians; one of which is the limited impact of the ethics
courses during their medical education. Therefore, there is need for
development of new models of medical ethics education that is more
attuned to local health problems and issues as well as strategies for
horizontal and vertical integration of ethics teaching with the rest of the
medical curriculum.
80
81
can be derived in a manner that reflects the real health needs of the
indigenous communities. Out of their narratives, this study follows a
Spinozan style of ethical analysis, which puts emphasis on the interrelated
aspects of knowledge system, positioning of laden interests, and the
formation of conative power to achieve the desired health outcomes.
82
feasibility of adopting a full disclosure policy and the extent to which such
a policy can help reduce administration and legal costs.
When an error occurs it has a physically, emotionally and economically
traumatizing effect upon the patient. Patients suffer a range of negative
emotions including: sadness, anxiety and depression. In addition, patients
are angered by the fact that the error was predictable and could have
been prevented and they fear that further errors or adverse events might
occur. In any case, documented research shows that the patients and
their families expect those responsible to acknowledge their error and
give a reason for the adverse event. It is well known that iatrogenic
injuries are accompanied by a high degree of tension in the patientodontologists relationship; patients want information about errors which
can occur during treatment; moreover, it is their right to receive such
information. At the same time, the odontologist staff should consider it
their moral and ethical duty to acknowledge errors and discuss them with
the patient and family.
Much more studies have to be carried out to be able to comprehend the
ethical and economic impact of a full error disclosure policy.
83
84
The report aims to fully explore the psychological and ethical aspects of
this important subject.
85
86
Key questions include: How valuable are non-human animal lives (what is
their moral status?)? What constitutes a good justification for taking
animals lives or causing them harm? Do most biomedical experiments
provide a strong enough justification for the use of animals? Should there
be limits on the amount of harm we can cause animals, and, if so, what
should these limits entail? The goal of this presentation is not to advocate
for a specific position, but to lay out the key normative issues and to
foster productive discussion.
87
RESPONSIBILITY CONSTRUCTION
Ines Giorgi, C. Sguazzin, Marina Manera, Italy
ines.giorgi@fsm.it
This talk focuses on the integration between responsibility principle and
hope principle according to Blochs perspective. In this theoretical
framework four clinical cases will be analyzed. Patients histories of life
and diseases offer breathing spaces about therapeutic choices and
sharing of responsibility through relations with different health care staff.
88
the younger generation must face in order to make conscious and mature
choices.
In this direction, our research group proposes to exceed the terms of the
conciliation, speaking rather of harmonization, both within the intrafamily dynamics and in the relationships between labor (defined as the
area of productive work) and family (understood not only as a
consumers unit, but as a group that produces a social capital).
From a bioethical and biopolitical point of view, all these argumentations
lead to the following consequences:
1. The bio-political governance of future and new families will no longer
apply the logic of contrast between work and family, as if there is an
opposition between the strict world of the market and the more
flexible rhythms required by the familial relationship.
2. The education in the medium and long term will have to invite the
younger generation to a process of mentalization, in which the
following bioethical themes will have an increasing relevance:
a) careful and informed management of human sexuality and fertility,
in a quest for a balance between different possibilities offered by
modern technologies in the field of medically assisted
reproduction (this one, moreover, is a field of new work close to
the family);
b) growth of affective, relational and sexual bonds of couple, who will
have to become more compatibles with times and regulations
still too strict of work environments, organizations and places;
c) relevance of the educational element, and not only in terms of
instruction and formation, in the definition of the essential
features which must have new families, which are small producers
of relational and social capital, giving priority to the themes of
human care, equal gender opportunities, welfare of children and
young people.
89
90
In any case, the clinical condition that lead to the Cesarean section (under
the patient request and /or under the physicians proposal) as well as
those conditions that results in failing to perform it (even through under
election request) should be duly reported on the patients medical record
and documented by various examination i.e. imaging, lab tests and
specialistic consultation.
As conclusion to provide the patient with the correct information is
fundamental not only to obtain her consent concerning therapeutic
options, but most of all, to favor therapeutic choices that do not have any
negative impact both on the pregnant patient and the fetus.
1,2
91
the health systems that in some cases are edging closer and closer toward
bankruptcy.
In respect to pharmaceutical companies profit and market share have
become the holy grail of both research and marketing. Has ethics been
overridden by commercialism and if so what are the repercussions?
92
93
of the term leads to different ethical, and hence legal and practical
approaches to end-of-life issues. Our particular focus is on: (1)
withdrawing/-holding life-sustaining treatment; (2) respect for patient
preferences; and (3) assistance in dying.
Given the difference in the understanding of dignity, and the underlying
philosophical approaches it feels that there is still a long way to go before
we can establish common guidelines on end-of-life decisions across
Europe and beyond. However clarifying the use of the term dignity in
different discussions around Europe could hopefully facilitate this
endeavour.
Adrian Hoxha , Genci Dervishi , Edjona Bici , Odela Risilia , Ola Hysaj ,
2
2
Imelda Kasapi , Klejda Risilia
1
Faculty of Medicine, Albania
2
National Association of Public Health, Albania
adrianhoxha@yahoo.com
Background: The health professionals (HP) by participating in ongoing
education trainings update their knowledge in accordance with the
criteria defined by the NCCE. Ethics and health communication was one of
the training modules.
Aim: Evaluation of training activities of HP in the field of ethics and health
communication.
Methodology: The study was conducted through an anonymous
questionnaire in 8 districts of Albania, in 2010 and 2012 and includes
participants in the ethics and health communication training as general
practitioners, pharmacists, managers and nursing staff. The data were
analyzed with statistical package SPSS 19.
Results: 194 HP participated in the training of ethics and health
communication. 32% of participants was male and 67% female. 30.9% of
the participants took part in 2010 and 69.1% of them in 2012. 46.9% were
general practitioners / family doctors, pharmacists 41.2%, 3.1% managers
and 8.3% nursing staff. 61.9% assessed as very high level the lecturer,
57.7% of them the subject content, 54.6% the audio-visual equipment,
58.2% discussion topics and 45,5% the hall where the training took place.
42.8% assessed the knowledge obtained in this training as very new. In
88.1% the participants stated that their expectations about the training
were fulfilled. The statistical analyzes indicate a moderate positive
correlative relation with 0,01 significance level between age and
assessment of new knowledge in these training activities.
Conclusion: It was noted that attendance doubled in 2012 compared with
2010. Older Professionals assessed the knowledge as new also because
their university curriculum did not include ethics and health
communications.
94
share the moral and ethical values and attitudes they are based on, occurs
(for example, euthanasia, authorization of same-sex marriages and
possibilities for such couples to enjoy assisted reproductive technologies
for their procreation, etc.).
Another risk is the legislative fixation of ethical principles acceptable for a
community, but with their formal utilization and emasculation of their
essence. The mandatory forms of informed consent diluting the essence
of the consenting process and the final authorization to research or
treatment is a significant example. This can also be exemplified by the
provisions appearing in legislations of the newly emerged states whereby
the independent ethics committees members are to be appointed by
the order of the health care institutions chief doctors.
At the same time, integration processes give great opportunities that
should be utilized to the fullest possible extent by all countries, especially
by the developing and the newly emerged ones. Implementation of the
best legal practices and solutions capable of resolving the burning issues
is one of such opportunities. In some newly emerged countries, for
example, there exists the issue of the two extracts from the medical
records when the patient suffering from a hard-to-treat disease
dangerous to life and his or her relative who the patients medical
information is disclosed to in full, get two extracts with different medical
data, including diagnosis. This situation can hardly be accepted from the
ethical and legal viewpoint. An important task is therefore the exchange
of experience and implementation of good solutions for such problems.
Cross-fertilization both between bioethics and health law and between
the bioethical models and legal doctrines dominating in different parts of
the world seems to be the main direction for the development.
Within the past three decades scientists (example, Koch, 2005) have
uncovered a wealth of difficult-to-measure habits of mind that lead
people to happy and fulfilled lives. These include persistence, learning
from ones mistakes, responsible risk-taking, controlling ones impulses,
listening and responding with empathy, reading people, situations and
ideas (Costa and Kallick, 2008). These scientists theorize that ones
character is formed within ones unconscious mind. Others, like
psychologist, Timothy Wilson (2002), contend that the unconscious mind
does all of the work. Contrastingly, scholars who study autism put forth
three prevailing theories, which identify the inability of an individual with
autism to recognize or understand others intentions (example: beliefs,
fears, desires or wants) the very elements that were identified as
building blocks to success (Barnbaum, 2008), Given the centrality of the
aforementioned qualities how might educators and their families work to
secure the moral compass of children with autism? The impetus for this
question stems from a service learning work experience that lead the
authors to lead a workshop for parents of children with autism. These
parents sought the knowledge, the expertise and key understandings
about how to direct the inner lives of their children. The authors hope
that the question they pose for discussion would generate ideas for
collaborating to both develop studies and outreach programs aimed at
assisting parents and educators of children with autism in less resourcerich countries where access to well-established therapies and resources
are scarce.
95
96
The objective of the present study is to discuss the reasons and the
solutions for the current need of Judicializing of the Private Health Care in
Brazil. The reasons for the transgressions committed by the Health
Insurance Plans to the detriment of rights and the interests of its insured.
The applicable penalties. What are the roles of the regulatory bodies?
Why does the State fail in promoting regulatory policies in this kind of
activity? The object of this discussion is the presentation of the Brazilian
reality, the solutions imposed by the Brazilian Judiciary Power and how
the companies in this segment act before the concession of judicial orders
in favor of the insured.
The civil and criminal liability of these companies agents and directors as
one of the feasible solutions. How the Brazilian legislation deals with the
issue. What are the legal applicable codes?
This study will allow the students, Law operators and health care
professionals to know, based on the Brazilian law and compared laws, the
difficulties and the solutions adopted by the Brazilian juridical system,
always considering the prevalence of the general principles of the Law,
and above all the principle of dignity of the human person over financial
and political interests.
97
98
Safety", "On drug treatment services" and etc. are among them. The most
important of them is the act adopted in 1997 the Law "On public health
protection of the Azerbaijan Republic."
Bioethical processes implemented today in Azerbaijan are carried out in
close integration with the international. The right to a decent life and to
health care is a basic inalienable right enjoyed by every citizen of the
country. Assigned to the group of the most important social and cultural
rights, health insuring and protection, integrity, dignity and autonomy of
man have been declared in the very first national legal acts, including the
national Constitution.
Following this discussion I will argue that the time has come for courts to
recognize the existence of a new head of damage, namely, interference
with the right to autonomy. According to this approach, when a patient's
right to autonomy is infringed, that patient suffers an injury for which he
is entitled to compensation. This injury is unrelated to the existence of
physical injury or to proof that a different decision would have been made
by the patient upon becoming fully informed.
I will argue that recognition of interference with the right to autonomy as
a new head of damage is commensurate with the idea of patient
autonomy underlying the doctrine of informed consent. I will further
claim that adoption of this rule is consistent with considerations of
deterrence. Finally, I will suggest that recognizing this new head of
damage provides a solution to issues that go beyond the framework of
informed consent, such as claims for wrongful birth or wrongful
pregnancy.
The patients right to autonomy has been protected under law through
the doctrine of informed consent for the past six decades.
From the mid- 1950s physicians have been under a legal and ethical duty
to inform the patient of proposed medical treatment. Ancillary to the
duty of disclosure is the physician's duty to receive the patients free
consent. At the heart of these rules stands the ex-ante recognition of the
patients right to autonomy.
However, apart from extreme cases which fall within the ambit of the tort
of assault, the patients right to autonomy receives protection ex-post
only if two conditions have been met: the patient suffered actual damage
and the patient can prove that had he been fully informed he would not
have consented to the treatment. Thus, protection of the right to
autonomy is subject to proof of actual damage and proof that a different
decision would have been made upon obtaining full information. A
patient whose right to autonomy has been infringed but who has not
suffered actual injury or cannot prove that he would have decided
differently is not entitled to compensation. Respectively, in neither of
these cases are legal sanctions imposed on the physician who infringed
the patient's right to autonomy.
Over the last few years as the number of patients diagnosed with autism
rose sharply, interest and discourse have greatly increased. At the center
of the discourse reside the many ethical questions that arise in autism.
The diagnosis of autism is relatively new and its definition changed over
the years thus resulting in a sharp increase in the number of patients
diagnosed with it.
A recent change though, resulted in a narrower definition. Thus many
people who were considered as having the disorder are suddenly
considered normative, raising significant ethical issues regarding the
power of professionals to maneuver diagnosis definitions, impacting
decisions on support and treatment for individuals.
Autism spectrum's definition includes people completely unable of
communicating and people with high cognitive and verbal ability, many of
whom claim to have just neurodiversity thus making diagnosis and
treatment unnecessary. They also object to research on changing
behavior patterns and on pre-natal genetic identification, diagnosis and
prevention in autism.
99
100
101
102
103
104
dysfunction. The ethical debate related to this topic stems from the
dichotomy between the principle of autonomy and the principle of
beneficence. The rights of ownership and the future use for research of
biological samples with an informed consent for actual use provided are
still an unresolved problem. However the binomial of research interests in
using this data with implications for the entire community, together with
the bioethical interest of constitutionally guaranteed rights protection has
to be taken into account. From this results the authors interest to suggest
methodologies for the accurate acquisition of consent that provide to the
patient detailed information on the aims, purposes and procedures of
biomarkers investigation. The purpose has been pursued by the draft of
an application format of information sheet and an informed consent.
They point out the possible value of biomarkers as early diagnosis and
monitoring tools in neurodegenerative diseases. This formats also clarify
that the identification in blood or CSF of some markers don't express a
definitive diagnosis and underline that, at present, their validity as disease
progression index is still uncertain.
105
The Human Organ Transplant Act (HOTA) in Singapore was enacted for
the removal of kidneys for the sole purpose of transplantation from
deaths arising from accidents under a system of presumed consent. Since
then, it has undergone a series of major amendments to include the
recovery of the liver, heart and cornea in the event of deaths from nonaccidental causes, and to make provisions for the inclusion of Muslims
and the removal of the upper age limit of 60 years old to increase the
number of donors. Recent amendments to this law have also included the
regulation of living donor organ transplantation and the more
controversial reimbursement of organ donors for their loss of earnings
and expenses pertaining to the transplantation. The purpose of this paper
is twofold. It traces the historical developments in Singapore that led to
the adoption of an approach in presuming the consent of individuals in
donating his organs upon death. In doing so, it addresses the challenges
that a policy of presumed consent to organ transplantation has
presented. Next, we review an instance in Singapores legal history in
which the strict prohibition on financial compensation for organ
transplantation was tested. Here, the legal justifications behind the
courts decision will be discussed in tandem with the prevailing theme of
exploitation of the poor and socially disadvantaged.
106